SCHEMBL278058

SCHEMBL278058

CCCCC/C=C/C/C=C/CCCCCCCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 1.00
PPARD Q03181 6/20 1.00
PPARA Q07869 6/20 1.00
ALDH1A1 P00352 5/20 1.00
F7 P08709 5/20 1.00
F3 P13726 5/20 1.00
FABP4 P15090 4/20 1.00
HSD17B10 Q99714 4/20 1.00
FFAR1 O14842 3/20 1.00
PTGS1 P23219 3/20 1.00
LMNA P02545 3/20 1.00
CYP19A1 P11511 3/20 1.00
ALOX15 P16050 3/20 1.00
NR4A2 P43354 3/20 1.00
KDM4E B2RXH2 2/20 1.00
CYP3A4 P08684 2/20 1.00
HPGD P15428 2/20 1.00
AKR1C3 P42330 2/20 1.00
TDP1 Q9NUW8 2/20 1.00
DUSP3 P51452 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16685715 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL15880317 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Linoleic Acid SCHEMBL20856202 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL22498259 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL22498256 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Arachidic Acid SCHEMBL20528087 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Linoleic Acid SCHEMBL25294178 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL22498258 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Dihomo-Gamma-Linolenic Acid SCHEMBL20656585 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL21411004 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 797 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025133227-A1 ANTI-GREY HAIR CARE COMPOSITIONS UNILEVER IP HOLDINGS B.V. (NL) 2025-06-26 WO claimed
US-20240327761-A1 CLEANING COMPOSITIONS AND METHODS OF USE THEREOF FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2024-10-03 US claimed
CN-118340759-A Compound essential oil for relieving primary dysmenorrhea and preparation method thereof 颇黎芳香医药科技(上海)有限公司 2024-07-16 CN claimed
CN-116660442-B Identification method for counterfeit yak milk or other animal milk doped in yak milk 中国农业科学院北京畜牧兽医研究所 2023-12-12 CN claimed
CN-116660442-A Identification method for counterfeit yak milk or other animal milk doped in yak milk 中国农业科学院北京畜牧兽医研究所 2023-08-29 CN claimed
US-11603512-B2 Cleaning compositions and methods of use thereof FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2023-03-14 US claimed
CN-115397572-A Cleaning compositions and methods of use thereof 富士胶片电子材料美国有限公司 2022-11-25 CN claimed
CN-115304509-A Ceramide compound containing chain carboxylic acid and preparation method and application thereof 深圳市迪克曼生物科技有限公司 2022-11-08 CN claimed
CN-113311098-B Method for measuring content of free fatty acid in breast milk 汤臣倍健股份有限公司 2022-07-29 CN claimed
CN-108727264-B Preparation method of naphthalimide diester fluorescent dye and composition thereof 斯佩特罗尼克斯公司 2022-04-26 CN claimed
US-6677470-B2 NOVEL COMPOSITIONS OF CONJUGATED LINOLEIC ACIDS; HUMAN AND ANIMAL NUTRITION NATURAL ASA (NO) 2004-01-13 US claimed
US-20030144353-A1 Functional acylglycerides NATURAL ASA (NO) 2003-07-31 US claimed
WO-2003043972-A2 FUNCTIONAL ACYLGLYCERIDES NATURAL AS (NO) 2003-05-30 WO claimed
WO-2003035051-A2 THE USE OF PROTON SEQUESTERING AGENTS IN DRUG FORMULATIONS INHALE THERAPEUTIC SYSTEMS, INC. (US) 2003-05-01 WO claimed
WO-2003005628-A2 GENERATING, VIEWING, INTERPRETING, AND UTILIZING A QUANTITATIVE DATABASE OF METABOLITES LIPOMICS TECHNOLOGIES, INC. (US) 2003-01-16 WO claimed
EP-0463454-B1 Transdermal administration to humans and animals DERMAMED (IL) 2001-09-26 EP claimed
US-6248890-B1 REACTING A NAPHTHALIMIDE DIOL WITH A FATTY ACID HAVING FROM 8 TO 24 CARBON ATOMS DAY-GLO COLOR CORP. 2001-06-19 US claimed
EP-0942717-A2 METHOD FOR CONTROLLING BODY FAT AND/OR BODY WEIGHT IN ANIMALS AND PHARMACEUTICAL COMPOSITIONS FOR USE THEREIN WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-09-22 EP claimed
EP-0889113-A2 Lubricating oil additives LUBRIZOL ADIBIS HOLDINGS (UK) LIMITED (GB) 1999-01-07 EP claimed
WO-1998024422-A2 METHOD FOR CONTROLLING BODY FAT AND/OR BODY WEIGHT IN ANIMALS AND PHARMACEUTICAL COMPOSITIONS FOR USE THEREIN WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1998-06-11 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144353-A1 Functional acylglycerides ELOVL3, CPT1B, ELOVL6 PPARG 67/4885PPARD 251/4885PPARA 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.